MultiplexDX

Cancer diagnostics, molecular testing, and research services for healthcare and life-science organizations

Bratislava, SlovakiaFounded 2016multiplexdx.com Website technologies

Highlights

GrowingRevenue +146% YoY (FY2025) · RÚZ
New on EvolcAdded 2026-10-25

About MultiplexDX

MultiplexDX develops cancer diagnostic tests using RNA-based visualization and sequencing, including Multiplex8+ for breast cancer. Its product and service portfolio also includes infectious-disease diagnostic kits, custom oligonucleotides, RNA sequencing, RNA FISH, and bioinformatics services.

The company serves diagnostic laboratories, healthcare organizations, research institutions, and biopharma companies. It sells diagnostic kits and research products and provides sequencing, bioinformatics, and companion-diagnostics services.

Founded in 2016, MultiplexDX is headquartered in Bratislava and has representation in U.S. and European markets. It received an EIC Accelerator grant and reports seed funding from Neulogy VC, Crowdberry, Ron Cook, and angel investors.

Product: Cancer diagnostic tests, infectious-disease kits, custom oligonucleotides, RNA sequencing, RNA FISH, and bioinformatics services.

Financials

Revenue (left axis)Net profit (right axis)

€0€5M€10M−€2M€0€2M€4M

FY2021€9.4M revenue€4.1M net profit

FY2022€2.5M revenue−€1.1M net profit

FY2023€582k revenue−€2.3M net profit

FY2024€1.5M revenue−€2.0M net profit

FY2025€3.8M revenue−€2.1M net profit

FY2021FY2022FY2023FY2024FY2025

	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	€3.8M	€1.5M	€582k	€2.5M	€9.4M
Growth	+146%	+163%	−76%	−74%	—
EBITDA	−€1.5M	−€1.5M	−€1.8M	−€723k	€4.6M
Operating profit	−€1.8M	−€1.9M	−€2.3M	−€1.1M	€4.4M
Net profit	−€2.1M	−€2.0M	−€2.3M	−€1.1M	€4.1M
Net margin	−54.8%	−132.2%	−389.9%	−45.5%	43%
Personnel costs	€1.8M	€1.1M	€1.1M	€1.5M	€1.2M
Total assets	€6.3M	€10.1M	€1.9M	€3.8M	€7.4M
Cash	€3.3M	€8.0M	€496k	€1.9M	€4.8M
Liabilities	€1.3M	€7.5M	€223k	€311k	€1.5M
Equity	€4.6M	€2.1M	€986k	€3.3M	€4.4M

As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.

Public contracts

Contracts MultiplexDX signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.

Customers

3 contracts with 3 buyers · €13.2M

	Contracts	Value
Úrad podpredsedu vlády SR pre Plán obnovy a znalostnú ekonomiku	1	€13.2M
Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica	1	—
Slovenská agentúra pre rozvoj investícií a obchodu (SARIO)	1	—

Open public tenders for MultiplexDX →

Suppliers

2 contracts with 2 suppliers · —

	Contracts	Value
Centrum spoločných činností Slovenskej akadémie vied, v.v.i.	1	—
Venture to Future Fund, a.s.	1	—

Latest contracts

18 Dec 2025 from Venture to Future Fund, a.s. · agreement on conversion terms concerning MultiplexDX from december 2025 register
9 Dec 2025 for Slovenská agentúra pre rozvoj investícií a obchodu (SARIO) · Zmluva o spolupráci a poskytnutí pomoci register
6 Nov 2025 for Úrad podpredsedu vlády SR pre Plán obnovy a znalostnú ekonomiku · Zmluva o poskytnutí dotácie · €13.2M register
31 Jul 2025 for Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica · Memorandum o spolupráci register
7 Jul 2025 from Centrum spoločných činností Slovenskej akadémie vied, v.v.i. · RÁMCOVÁ ZMLUVA O SPOLUPRÁCI A POSKYTNUTÍ POMOCI register

Jobs at MultiplexDX

No open positions listed right now.

Leadership

Vladimir Wolf · Co-founder
Source: company website
Pavol Cekan · Founder/CEO
Source: company website
Petra Lipnicka · COO
Source: company website

More biotech & pharma companies

NOVYSIAN
Dietary supplements for mental health, digestive and respiratory conditions, aimed at patients and healthcare professionals in Slovakia
Bratislava, SlovakiaBiotech & pharmaFounded 2024
Young company
OH SK
Private label development and certified manufacturer sourcing for medical and pharma brands in the EU
Bratislava, SlovakiaBiotech & pharmaFounded 2022
Young companyProfitableGrowing
REGES
Pharmaceutical and medical device distribution from manufacturers to pharmacies and healthcare facilities
Zvolen, SlovakiaBiotech & pharmaFounded 2023
Young companyGrowing
ReKoMBe
Production and purification of recombinant proteins and peptides, DNA sequencing and lab solution consulting for biotech clients
Bratislava, SlovakiaBiotech & pharmaFounded 2022
Young companyProfitableGrowing
SanaClis
Full-service clinical research and clinical supply chain services for pharma, biotech and medical device sponsors
Bratislava, SlovakiaBiotech & pharmaFounded 20014 open jobs
ProfitableNew on Evolc
SAVA PHARM
Italian-made linear hyaluronic acid joint injections for osteoarthritis, offered to clinics and institutions
Bratislava, SlovakiaBiotech & pharmaFounded 2026
Young companyNew on Evolc